Therapeutic Control of Aspirin-Exacerbated Respiratory Disease.

Trial Profile

Therapeutic Control of Aspirin-Exacerbated Respiratory Disease.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs Prasugrel (Primary) ; Aspirin
  • Indications Asthma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 04 Jan 2017 Status changed from recruiting to active, no longer recruiting.
    • 25 Apr 2016 Planned End Date changed from 1 Jan 2016 to 1 Mar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top